Navigation Links
Abbott Statement on the Results of the AIM-HIGH Study Presented at AHA 2011
Date:11/15/2011

ine.  

Patients with additional questions are advised to contact their health care provider or Abbott's medical information line in the United States at 1-866-257-8292, or visit www.niaspan.com.

Uses for Niaspan® (niacin extended-release tablets)

Niaspan is a prescription medication used along with diet when a low-cholesterol diet and exercise alone are not enough.

  • Niaspan raises HDL ("good") cholesterol and lowers LDL ("bad") cholesterol and triglycerides in people with abnormal cholesterol levels.
  • Niaspan is also used to lower the risk of heart attack in people who have had a heart attack and have high cholesterol.
  • In people with coronary artery disease and high cholesterol levels, Niaspan, when used with a bile acid-binding resin (another cholesterol medicine), can slow down or lessen the build up of plaque (fatty deposits) in your arteries.
  • Niaspan can be used in combination with lovastatin or simvastatin to improve abnormal cholesterol levels when taking Niaspan, simvastatin, or lovastatin alone is not enough.
  • No additional benefit of Niaspan on heart disease has been demonstrated when used with simvastatin or lovastatin over that shown for niacin, simvastatin, or lovastatin alone.

Important Safety Information for Niaspan

  • Niaspan is not for people with liver problems, stomach ulcers, serious bleeding problems, or those allergic to any product ingredient.
  • Severe liver damage can occur when switching to a long-acting niacin (Niaspan) from immediate-release niacin.  Do not switch between forms of niacin without talking to your health care provider.
  • Tell your health care provider about any unexplained muscle pain, tenderness or weakness, as this could be a sign of a serious side effect.  This risk may be increased w
    '/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility
2. PATH, Abbott and the Abbott Fund Form Innovative Partnership to Prevent Malnutrition
3. Perrigo Confirms Filing for Testosterone Gel 1.0% and Announcement of Patent Infringement Lawsuit by Abbott
4. Experts Report that Abbotts New PLEX-ID Assay Offers Important Testing Capabilities for Biothreat Defense
5. Abbott Awards CFCareForward Scholarships to Two Students Living With Cystic Fibrosis Pursuing Undergraduate and Graduate Degrees
6. Abbotts Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA
7. Abbott Honored With Asian CSR Award for Leadership in Science Education
8. Neurocrine Biosciences Receives Second Milestone Payment of $20 Million Under Abbott Collaboration Agreement
9. Zacks Industry Outlook Highlights: Vertex Pharma, AstraZeneca, Abbott Labs, Allergan and Onyx Pharmaceuticals
10. Abbott Receives CE Mark for Healon EndoCoat Protective Gel for Cataract Surgery
11. Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrition Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Manufacturers, suppliers and distributors of innovative medical-related ... their most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the ... the most litigious industry sectors of cases involving ...
(Date:1/15/2014)... Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), a ... a non-invasive, wireless continuous glucose monitoring system, today announced ... Interim CEO of Echo Therapeutics, will present at "TEN", ... Mr. Doman will make a corporate presentation ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
... , LAKE FOREST, Ill. , ... and manufacturer of injectable pharmaceuticals, announced today the acquisition ... number of products in development from GeneraMedix Inc. , ... additions to our portfolio, which demonstrates our continuing commitment ...
... , KINGWOOD, Texas , Feb. 12 ... that the company has formally offered to purchase an equity ... in the chronic pain management medical sector. The pharmaceutical company ... identified until IMAI has a signed letter of intent from ...
Cached Medicine Technology:Bioniche Pharma Acquires Seven New Products From GeneraMedix Inc. 2International Merchant Advisors, Inc. Offers to Invest in Pharmaceutical Chain 2
(Date:4/17/2014)... April 17, 2014U.S. military personnel who served in ... concussive traumatic brain injury (TBI) were compared to ... other medical reasons. Differences in measures of overall ... months after injury are reported in an article ... journal from Mary Ann Liebert, Inc., publishers. The ...
(Date:4/17/2014)... discovering a new mechanism that allows blood to enter ... Irvine and the Salk Institute have opened the door ... brain damage. , A complex and devastating neurological condition, ... reason for disability in the U.S. The blood-brain barrier ... material into the brain, causing the permanent deficits in ...
(Date:4/17/2014)... An international research team led by Cesar A. Arias, ... Center at Houston (UTHealth) has identified a new superbug ... The report appeared in the April 17 issue of ... The new superbug is part of a class of ... or MRSA, which is a major cause of hospital ...
(Date:4/17/2014)... D.C. -- The world is less than 40 years ... implications for people and governments, according to a top ... the first time in human history, food production will ... of land, water and energy," said Dr. Fred Davies, ... security. "Food issues could become as politically destabilizing by ...
(Date:4/17/2014)... lost its status as the leading weapon against the ... life, with new research indicating it simply needs to ... use of the cheap anti-malarial drug chloroquine in treating ... of more than half a million people each year ... has developed resistance to chloroquine, but research carried out ...
Breaking Medicine News(10 mins):Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:New MRSA superbug emerges in Brazil 2Health News:Food shortages could be most critical world issue by mid-century 2Health News:Scientists find new way to fight malaria drug resistance 2
... Drug Trend for 2008-- Drug Trend managed to a ... than 40 percent mail order experienced a negative drug ... inflation hit its highest level in five years, but ... growth to 3.3 percent, a new report released by ...
... of hereditary hemochromatosis , is frequently found in ... non-alcoholic fatty liver disease patients . A study ... and steatosis in a non-obese cohort of non-alcoholic ... after exclusion of diagnosis of HH, represent a ...
... (NPR-B) gene was expressed in gastric smooth muscles ... was increased in diabetic rats. These results suggest ... it may contribute to diabetic gastroparesis in STZ-induced ... is frequent in diabetic patients. It is a ...
... Mango, the very popular and fastest-growing retailer of authentic ... "AKA" seal, a certification confirming that Red Mango,s frozen ... high quality, delicious treat by nationally recognized Celebrity Dietitian ... and nutritionist in Los Angeles by Citysearch.com for the ...
... Caron Treatment Centers Poll Examines Challenges , Women ... EmpowermentPHILADELPHIA, May 13 From decreased intimacy ... is having a profound impact on relationships, according to ... Centers , one of the nation,s leading non-profit ...
... CareFusion Corporation, the company that will become public ... medical products businesses, today announced that Edward J. Borkowski ... has been CFO of Mylan, Inc. since 2002 where ... business to one of the largest generic pharmaceutical companies ...
Cached Medicine News:Health News:Mail Service and Higher Generic Use Helps Keep Spending in Check, Countering Brand Drug Price Inflation and Specialty Medication Growth 2Health News:Mail Service and Higher Generic Use Helps Keep Spending in Check, Countering Brand Drug Price Inflation and Specialty Medication Growth 3Health News:Mail Service and Higher Generic Use Helps Keep Spending in Check, Countering Brand Drug Price Inflation and Specialty Medication Growth 4Health News:Mail Service and Higher Generic Use Helps Keep Spending in Check, Countering Brand Drug Price Inflation and Specialty Medication Growth 5Health News:NPs-NPR-B/pGC-cGMP signal pathway is involved in diabetic gastroparesis 2Health News:Red Mango Receives 'AKA' Stamp of Approval From Ashley Koff, R.D., Underscoring Its Commitment to Good Health 2Health News:Red Mango Receives 'AKA' Stamp of Approval From Ashley Koff, R.D., Underscoring Its Commitment to Good Health 3Health News:New Study Shows Stresses of Economic Downturn on Women's Relationships 2Health News:New Study Shows Stresses of Economic Downturn on Women's Relationships 3Health News:New Study Shows Stresses of Economic Downturn on Women's Relationships 4Health News:New Study Shows Stresses of Economic Downturn on Women's Relationships 5Health News:CareFusion Names Edward Borkowski as Chief Financial Officer 2Health News:CareFusion Names Edward Borkowski as Chief Financial Officer 3Health News:CareFusion Names Edward Borkowski as Chief Financial Officer 4
The combination of new measuring principle - Pupil Zone Imaging Method - and unique technology - SLD - offers high accuracy and reliability in refraction measurement....
... Module ACM-8 loads and unloads two centrifuges ... Identification via Cap Recognition the tube type ... in batches of three 5 position racks ... the single centrifuge ACM can be offered ...
... The Recapping System RCS 800 closes various ... efficient and easy way. Different tube heights and ... sealed tubes can be used for send-outs. The ... RSD 800, Aliquoting System RSD 800 and High ...
... detect sequences of the following viruses: ... and 3; influenza virus A and ... and B. Laboratories may use ... *Analyte Specific Reagents. Analytical ...
Medicine Products: